Roche
RO.SW
#41
Rank
A$463.51 B
Marketcap
A$582.59
Share price
-0.06%
Change (1 day)
20.61%
Change (1 year)

Roche (RO.SW) - Cash on Hand

Cash on Hand as of December 2025 : A$27.04 Billion

According to Roche's latest financial reports the company has A$27.04 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Roche - Cash on Hand chart (from 2006 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$29.18 B-5.32%
2024-12-31A$30.82 B67.99%
2023-12-31A$18.34 B18.1%
2022-12-31A$15.53 B-21.02%
2021-12-31A$19.67 B8.12%
2020-12-31A$18.19 B4.06%
2019-12-31A$17.48 B-7.64%
2018-12-31A$18.93 B19.96%
2017-12-31A$15.78 B27.25%
2016-12-31A$12.40 B-2.67%
2015-12-31A$12.74 B-11.92%
2014-12-31A$14.46 B-4.08%
2013-12-31A$15.08 B2.23%
2012-12-31A$14.75 B25.72%
2011-12-31A$11.73 B2.18%
2010-12-31A$11.48 B-42.48%
2009-12-31A$19.96 B-29.27%
2008-12-31A$28.22 B15.44%
2007-12-31A$24.45 B-3.61%
2006-12-31A$25.37 B16.95%
2005-12-31A$21.69 B47.28%
2004-12-31A$14.72 B-15.89%
2003-12-31A$17.51 B-51.42%
2002-12-31A$36.04 B-41.6%
2001-12-31A$61.71 B30.25%
2000-12-31A$47.38 B28.63%
1999-12-31A$36.83 B9.47%
1998-12-31A$33.65 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
A$27.80 B 2.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$15.95 B-41.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$18.80 B-30.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$12.36 B-54.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.62 B-53.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$13.75 B-49.12%๐Ÿ‡ซ๐Ÿ‡ท France
Becton Dickinson
BDX
A$1.03 B-96.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$20.14 B-25.49%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.88 B-78.24%๐Ÿ‡ฌ๐Ÿ‡ง UK